Elucidating and Utilising the Mechanisms Used by Pseudomonas aeruginosa to Develop Resistance to Bacteriophages to Aid Therapeutic Formulation and Application in Cystic Fibrosis
Antimicrobial resistance (AMR) is one of the greatest threats to human healthcare and this thesis explored the use of bacteriophages to treat Pseudomonas aeruginosa infections. Firstly, responses of clinical isolates of P. aeruginosa to phage treatments were investigated and mechanisms of resistance...
| Main Author: | Vaitekenas, Andrew |
|---|---|
| Format: | Thesis |
| Published: |
Curtin University
2023
|
| Online Access: | http://hdl.handle.net/20.500.11937/95174 |
Similar Items
Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)
by: Webb, Karmel
Published: (2022)
Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)
by: Palser, Sally C.
Published: (2024)
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)
by: Hurley, M.N., et al.
Published: (2012)
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)
by: Langton Hewer, Simon C., et al.
Published: (2014)
Can aerosolised bacteriophage preparations against Pseudomonas aeruginosa protect against endotoxin-mediated inflammation in the lungs of people with cystic fibrosis?
by: Trend, S., et al.
Published: (2016)
by: Trend, S., et al.
Published: (2016)
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
by: Barr, Helen L., et al.
Published: (2015)
by: Barr, Helen L., et al.
Published: (2015)
Lectin-mediated biofilm maturation, quorum sensing and Pseudomonas aeruginosa infections in cystic fibrosis
by: Crusz, S.A.
Published: (2009)
by: Crusz, S.A.
Published: (2009)
Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans
by: Costello, A., et al.
Published: (2014)
by: Costello, A., et al.
Published: (2014)
Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Gilchrist, Francis J., et al.
Published: (2015)
by: Gilchrist, Francis J., et al.
Published: (2015)
HOST DEFENCE PEPTIDE AS AN INNOVATIVE NOVEL THERAPY FOR PSEUDOMONAS AERUGINOSA BIOFILM INFECTIONS IN THE CYSTIC FIBROSIS LUNG
by: Wannigama, D., et al.
Published: (2019)
by: Wannigama, D., et al.
Published: (2019)
Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)
by: Spencer, Daniella Lucy
Published: (2019)
Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2016)
by: Hurley, Matthew, et al.
Published: (2016)
Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection
by: Darch, Sophie E., et al.
Published: (2015)
by: Darch, Sophie E., et al.
Published: (2015)
Elucidating the mechanism of action of novel lactams on Pseudomonas aeruginosa
by: Pantalone, P.
Published: (2019)
by: Pantalone, P.
Published: (2019)
Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
by: Palser, Sally C., et al.
Published: (2016)
by: Palser, Sally C., et al.
Published: (2016)
PRIMARY AIRWAY EPITHELIAL CELL RESPONSES TO BACTERIOPHAGE PREPARATIONS TO TREAT INFECTION IN CYSTIC FIBROSIS
by: Trend, S., et al.
Published: (2017)
by: Trend, S., et al.
Published: (2017)
The use of magnetic resonance imaging to elucidate the mechanisms of gastrointestinal symptoms and complications in cystic fibrosis
by: Ng, Christabella
Published: (2022)
by: Ng, Christabella
Published: (2022)
Cystic Fibrosis isolates of Pseudomonas aeruginosa retain iron-regulated antimicrobial activity against Staphylococcus aureus through the action of multiple alkylquinolones
by: Nguyen, Angela T., et al.
Published: (2016)
by: Nguyen, Angela T., et al.
Published: (2016)
The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
by: Trend, S., et al.
Published: (2017)
by: Trend, S., et al.
Published: (2017)
Neutrophil Elastase Activity During Episodes Of Pseudomonas Infection In Early Cystic Fibrosis
by: Garratt, L.W., et al.
Published: (2016)
by: Garratt, L.W., et al.
Published: (2016)
Evaluation of the bacteriophage MAC-1 potential to control pseudomonas aeruginosa planktonic cells and biofilms
by: Aqeel, Moaz, et al.
Published: (2024)
by: Aqeel, Moaz, et al.
Published: (2024)
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study
by: Barr, Helen L., et al.
Published: (2017)
by: Barr, Helen L., et al.
Published: (2017)
US Cystic Fibrosis Foundation and European Cystic
Fibrosis Society consensus recommendations for the
management of non-tuberculous mycobacteria
in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)
by: Floto, R. Andres, et al.
Published: (2016)
NEUTROPHIL ELASTASE ACTIVITY IN EARLY CYSTIC FIBROSIS PRIOR TO, DURING AND POST PSEUDOMONAS INFECTION
by: Garratt, L., et al.
Published: (2016)
by: Garratt, L., et al.
Published: (2016)
Direct and Rapid Electrochemical Detection of Pseudomonas aeruginosa Quorum Signaling Molecules in Bacterial Cultures and Cystic Fibrosis Sputum Samples through Cationic Surfactant-Assisted Membrane Disruption
by: Buzid, A., et al.
Published: (2017)
by: Buzid, A., et al.
Published: (2017)
Crystallization and structure elucidation of recombinant Pseudomonas aeruginosa strain K solvent tolerant elastase
by: Mat Said, Zatty Syamimi@Adura
Published: (2014)
by: Mat Said, Zatty Syamimi@Adura
Published: (2014)
Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey
by: Mac Aogáin, M., et al.
Published: (2012)
by: Mac Aogáin, M., et al.
Published: (2012)
Interventions for the eradication of meticillin-resistant
Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)
by: Smyth, Alan R.
Published: (2015)
Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)
by: Maxwell, Susannah, et al.
Published: (2011)
Riboregulation in Pseudomonas aeruginosa
by: Silistre, Hazel
Published: (2016)
by: Silistre, Hazel
Published: (2016)
Free neutrophil elastase activity in airways of young children with cystic fibrosis prior to, during and post-Pseudomonas infection
by: Garratt, L., et al.
Published: (2016)
by: Garratt, L., et al.
Published: (2016)
Metabolic functions of the Pseudomonas aeruginosa aminoglycoside resistance gene, aph
by: Aksoy, Cemile Selin
Published: (2024)
by: Aksoy, Cemile Selin
Published: (2024)
Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)
by: Subbarao, P., et al.
Published: (2015)
Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)
by: Hurley, M.N., et al.
Published: (2011)
Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)
by: Waters, Valerie, et al.
Published: (2015)
Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
sTREM-1 is elevated in cystic fibrosis and correlates with proteases
by: Forrester, D.L., et al.
Published: (2017)
by: Forrester, D.L., et al.
Published: (2017)
Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)
by: Jain, Kamini
Published: (2018)
METABOLOMIC RESPONSE OF HEALTHY AND CYSTIC FIBROSIS EPITHELIUM TO RHINOVIRUS
by: Agudelo-Romero, P., et al.
Published: (2019)
by: Agudelo-Romero, P., et al.
Published: (2019)
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)
by: Thomson, E., et al.
Published: (2010)
Similar Items
-
Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022) -
Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024) -
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012) -
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014) -
Can aerosolised bacteriophage preparations against Pseudomonas aeruginosa protect against endotoxin-mediated inflammation in the lungs of people with cystic fibrosis?
by: Trend, S., et al.
Published: (2016)